FFAR3 and obesity disorder: Among GPCRs, GPR41 and GPR43 have been identified as receptors for short-chain fatty acids (SCFAs), which are representative metabolites of the gut microbiota and reported to contribute to anti-obesity effects and hepatic metabolic improvements20–23.